Because of the prothrombotic state associated with diabetes, the evaluation of the efficacy of antiplatelet monotherapy after 3-months DAPT compared to 12-months DAPT with aspirin and a P2Y12 inhibitor for among patients with diabetes is of major importance. The gene discussed is P2RY12; the disease is diabetes mellitus.